AbbVie Inc revenue growth has been varied year-over-year.

What is ABBV's revenue growth rate?

Historical revenue data is available for AbbVie Inc to analyze growth trends.

How fast is ABBV earnings growing?

Earnings growth data is available for AbbVie Inc analysis.

What is ABBV's profit margin?

Profit margin data is available for AbbVie Inc.

ABBV Revenue & Earnings Growth Analysis 2026 - Is AbbVie Inc Growing?

Growth Summary

AbbVie Inc (ABBV) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

Over the past 4 years, AbbVie Inc has achieved a revenue compound annual growth rate (CAGR) of 43.8%, while earnings have grown at -3.5% CAGR.

Latest Revenue

$61.16B

Net Income

$4.23B

5-Year Revenue CAGR

43.8%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for AbbVie Inc

The chart above illustrates AbbVie Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of AbbVie Inc's business.

Profit Margin Trends

How efficiently AbbVie Inc converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue AbbVie Inc retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$14.53

Current: $2.37

EPS Estimate 2027

$16.11

10.9% expected growth

Price Target

$248.69

Analyst consensus

What Analysts Are Saying

Wall Street analysts project AbbVie Inc to continue growing earnings in the coming year. The consensus analyst rating is 4 based on 28 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, AbbVie Inc (ABBV) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 43.8% CAGR over 4 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of AbbVie Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.